A multicenter, open-label, randomized controlled trial enrolled 100 patients with BAD-related mild stroke (NIH Stroke Scale score ≤5) across four centers in China. All patients were treated within 48 ...

The primary clinical outcome was the modified Rankin Scale (mRS) score at 90 days, while the secondary outcome was the NIH Stroke Scale (NIHSS) score at 24 hours. This study highlights the prognostic ...